Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs;Neutropénie chez un patient traité avec la clozapine dans le contexte d'une polypharmacie

Encephale

Volumn 28, Issue 6 I, 2002, Pages 567-569

  Senechal A ^a   Landry, P ^a   Deschamps, R ^a   Lessard, M ^a  

^a NONE

Author keywords

Antipsychotic; Clozapine; Neutropenia; Polypharmacy; Schizophrenia

Indexed keywords

CLOZAPINE; COTRIMOXAZOLE; DEFIBROTIDE; ERYTHROMYCIN; HALOPERIDOL; LEVOMEPROMAZINE; PAROXETINE; PSYCHOTROPIC AGENT; RISPERIDONE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; HUMAN; LEUKOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHIL; REMISSION; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036875165     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ATKIN K, KENDALL F, GOULD D et al. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996; 169: 483-8.
2. DERNOVSEK Z, TAVCAR R. Risperidone-induced leucopenia and neutropenia. Br J Psychiatry 1997; 171: 393-4.
3. EDELMAN RJ. Risperidone side effects. J Child Adolesc Psychiatry 1996; 35: 4-5.
4. ETAIN B, ROUBAUD L, LE HENZEY MF etal. Un cas de leucopénie sous traitement par rispéridone chez un adolescent. Encephale 2000; 26: 81-8.
5. FINKEL B, LERNER AG, OYFFE I et al. Risperidone-associated agranulocytosis. Am J Psychiatry 1998; 155: 855-6.
6. GALLIN JI. Anomalies quantitatives et qualitatives des phagocytes. In: Harrison TR, ed. Paris: McGraw-Hill, 1995.
7. GEORGE TP, INNAMORATO L, SERNYAK MJ et al. Leukopenia associated with addition of paroxetine to clozapine. J Clin Psychiatry 1998; 59: 31.
8. GODLESKI LS, SERNYAK MJ. Agranulocytosis after addition of risperidone to clozapine traitment. Am J Psychiatry 1996; 153: 735-6.
9. GURY C, BERCHOT F, FABRE C et al. Analyse des prescriptions de neuroleptiques dans cinq centres hospitaliers spécialisés. Inform Psychiatr 2000; 8: 954-63.
10. HENDERSON DC, BORBA CP. Trimethoprim-sulfamethoxazole and clozapine. Psychiatr Serv 2001; 52: 111-2.
11. KANE J, HONIGFLED G, SINGER J et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine/benztropine. Arch Gen Psychiatry 1988; 45: 789-96.
12. LAMARQUE V. Effets hématologiques de la clozapine: bilan de l'expérience internationale. Encephale 1996; 22: 35-6.
13. PANTELIS C, ADESANYA A. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine. Aust NZ Psychiatry 2001; 35: 544-5.
14. PEACOCK L, GERLACH J. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices. J Clin Psychiatry 1994; 55: 44-9.
15. RITTMANNSBERGER H, MEISE U, SCHAUFLINGER K et al. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999; 14: 33-40.
16. TOHEN M, CASTILLO J, BALDESSARINI RJ et al. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry 1995; 152: 413-8.
17. USISKIN SI, NICOLSON R, LENAVE M et al. Retreatment with clozapine after erythromycin-induced neutropenia. Am J Psychiatry 2000; 157: 1021.